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Streptomyces rocheiMHM13Abstract The study investigated silver nanoparticles (AgNPs) synthesized extracellularly using an
actinomycete isolated from sediment of the Suez Gulf, Red Sea, Egypt. Screening for biosynthesis
of AgNPs revealed that among the forty one actinomycetes tested, only two exhibited the ability to
synthesize AgNPs with antibacterial activity. The most potent isolate was selected and identiﬁed as
Streptomyces rochei MHM13 (accession number KR108310) on the basis of morphological and
physiological properties, together with 16S rRNA sequence. The biosynthesized AgNPs signiﬁ-
cantly inhibited the growth of medically important pathogenic bacteria (Vibrio fluvialis, Pseu-
domonas aeruginosa, Salmonella typhimurium, Vibrio damsela, Escherichia coli, Bacillus subtilis,
Staphylococcus aureus, Bacillus cereus). The biosynthesized AgNPs were achieved by addition of sil-
ver nitrate (1 mM) to the culture supernatant and monitored by colour change after incubation then
characterized by UV–Visible spectrophotometer, X-ray, Fourier transform-infrared spectroscopy
and scanning electron microscopy. The obtained AgNPs are spherical in shape with a particle size
of 22–85 nm. Plackett–Burman design was employed for optimization of the culture conditions for
the production of AgNPs by S. rochei. Synergetic effect of AgNPs with six different antibiotics was
evaluated. The microbiologically synthesized silver nanoparticles acted as an anti-biofouling agent.
Moreover, silver nanoparticles exhibited a signiﬁcant degree of anticancer activity against ﬁve dif-
ferent tumour cell lines.
 2016 National Institute of Oceanography and Fisheries. Hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Nanotechnology is a science, dealing with the synthesis of
nanoscale materials (range in size from 1 to 100 nm) (Zarina
and Nanda, 2014a,b), and their applications. The metallic
nanoparticles have various categories including gold, silver,
302 H.M. Abd-Elnaby et al.alloy, zinc and others (Singh et al., 2014a,b; Bhosale et al.,
2015).
Silver nanoparticles have considerable attention among
metal nanomaterials, due to their physicochemical properties
(Abdeen et al., 2014). They are in great demand due to their
widespread applications e.g., antimicrobials and therapeutics,
bimolecular detection, biolabeling, catalysis and microelec-
tronics, nonlinear optics and intercalation materials for electri-
cal batteries (Rai et al., 2009; Zarina and Nanda, 2014a;
Golinska et al., 2014).
Biological synthesis of metal nanoparticles has been well
achieved by different microorganisms (Golinska et al., 2014;
Zarina and Nanda, 2014a). Actinomycetes are considered an
important resource for new products of medical and industrial
interest such as antimicrobial agents (Bhosale et al., 2015;
Mohamedin et al., 2015). They are being used as ecofriendly
nanofactories (Deepa et al., 2013; Abdeen et al., 2014;
Lakhsmi et al., 2015). Actinomycetes are efﬁcient candidates
for metal nanoparticles production extracellularly and intra-
cellularly. The synthesis of nanoparticles by actinomycetes rep-
resent good stability and polydispersity. Actinomycetes
possess important biocidal activity against different pathogens
(El-Naggar and Abdelwahed, 2014; Golinska et al., 2014;
Mohamedin et al., 2015). Moreover, it can be manipulated
genetically in order to provide better control over size
(Bhosale et al., 2015).
Optimization of the growth conditions, such as media com-
ponents, pH, temperature, substrate concentration and inocu-
lum size will not only support the growth but also enhance the
productivity and monitor the rate of enzyme activity which
affects the synthesis of silver nanoparticles (El-Naggar and
Abdelwahed, 2014; Singh et al., 2014b; Iravani, 2014;
Mohamedin et al., 2015).
Statistical experimental designs depend on many steps of
an optimization strategy, such as searching for optimal
conditions of the targeted factor or for screening experiments
(Yue et al., 2012; El-Naggar and Abdelwahed, 2014;
Mohamedin et al., 2015). Plackett–Burman design is one of
the popular and economic choices for bio-processing (Kiran
et al., 2010; El-Naggar and Abdelwahed, 2014; Mohamedin
et al., 2015).
This study investigates the antibacterial activity and
characterization of AgNPs synthesized extracellularly by
Streptomyces rochei MHM13 isolated from sediment of
the Suez Gulf, Red Sea, Egypt. The study extent is to
optimize the culture conditions using Plackett–Burman
Design. Also, the anticancer activity of silver nanoparticles
was assessed.Materials and methods
Actinomycetes growth conditions
A total of forty one actinomycete isolates representing
different colony morphologies were isolated from sediment
samples along Suez Gulf, Red Sea, Egypt, during February,
2015. Actinomycetes were cultivated on starch-nitrate medium
(Abou-Elela et al., 2009) with the following components (g ll):
20 starch, 0.5 K2HPO4, 1 KNO3, 0.5 MgSO47H2O, 0.01
FeSO4, 15 agar (for solid medium), pH 7 and incubation was
performed at 30–32 C for seven days.Pathogenic indicators
The bacterial pathogens were Bacillus subtilis 6633, Staphylo-
coccus aureus 25,923, Pseudomonas aeruginosa 9027, Bacillus
cereus, Salmonella typhimurium 14,028, Escherichia coli
19,404, Vibrio fluvialis and Vibrio damsela.
Preparation of cell free extract
Each isolate from the forty one actinomycetes was inoculated
in 250 ml ﬂask containing starch-nitrate medium (50 ml). Inoc-
ulated ﬂasks were incubated in a rotary shaker at 200 rpm and
30–32 C for seven days. After incubation, each culture was
centrifuged at 12,000 rpm and its supernatant was used for fur-
ther experiments (Selvakumar et al., 2012).
Biosynthesis of silver nanoparticles (AgNPs)
Aqueous solution of 1 mM silver nitrate (50 ml,) was mixed
with actinomycete supernatants (50 ml) and the pH was
adjusted to 8.5. The mixture was incubated in a rotary shaker
at 37 C and 200 rpm in the dark for 5 days. Control experi-
ments were performed with un-inoculated media and silver
nitrate solution to check the role of bacteria in the nanoparti-
cle synthesis. The silver ions reduction was examined by sam-
pling about 2 ml of the solution at time intervals and
monitoring the UV–Vis spectra by using UV–Vis spectropho-
tometer (Double Beam Spectrophotometer 6800 JENWAY).
In each reaction vessel colour change was observed to yellow-
ish brown in the silver nitrate solution incubated with actino-
mycetes supernatant (Selvakumar et al., 2012).
Antibacterial assay
The antagonistic activity of the biosynthesized AgNPs was
tested by well-cut diffusion technique, in which, wells (5-mm)
were punched in Muller Hinton agar (Oxoid Ltd, England)
plates inoculated with pathogenic bacteria. Fifty microlitres
of AgNPs were pipetted into each well. After incubation at
37 C overnight, the radius of the inhibition zone around each
well was measured in mm (Priyaragini et al., 2013). This test
was done in duplicate.
Identification of the most potent isolate
Genotypic characterization
DNA of the selected actinomycetes isolate was extracted and
puriﬁed. The region of 16S rDNA was ampliﬁed using either
species speciﬁc primers or universal primers. Genotypic char-
acterization was carried out by using 16S sequence analysis.
Finally, the multiple alignments with sequences of most closely
related members and the levels of sequence similarity were per-
formed using Bioedit (Hall, 1999). For comparison, Sequences
of rRNA genes were detected from the database of NCBI.
Phenotypic characterization
The morphological, cultural, physiological, biochemical char-
acteristics for the selected actinomycete isolate were performed
according to standard procedure of Bergey’s Manual of Deter-
minative Bacteriology (Ravikumar and Krishnakumar, 2010).
Table 1 Independent variables affecting antibacterial activity
of silver nanoparticles.
Factor Symbol Level
1 0 +1
Starch (g l1) Starch 10 20 30
KNO3 (g l
1) KN 0.5 1.0 1.5
K2HPO4 (g l
1) K2 0.25 0.5 0.75
MgSO47H2O (g l1) Mg 0.25 0.5 0.75
FeSO4(g l
1) Fe 0.005 0.01 0.015
Temperature (C) Temp 33 35 37
pH pH 6.5 7.5 8.5
*Inoculum size was added as 1 ml of 7 days culture
(103 CFU ml1).
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The selected actinomycetes’ isolate was cultured in starch
nitrate agar medium and incubated at 30–32 C for 14 days.
A specimen of the culture was ﬁxed in glutaraldehyde (2.5%,
v/v), and washed by water, then, post-ﬁxed in 1%, w/v osmium
tetroxide for one hour. The sample was washed with water
(twice) and dehydrated by ascending concentrations of ethanol
(30–100%, v/v). The sample was coated by gold and examined
at 15–20 kV by scanning electron microscope (JEOL JSM 5400
LV), Japan, at the electron microscope unit of Assiut Univer-
sity, Egypt.
Confirmation for the presence of extracellular silver
nanoparticles
UV–Visible spectroscopy (UV–Vis)
The bioreduction of silver ions was monitored by colour
change from pale yellow to brown. Further, it was conﬁrmed
by sharp peaks observed by the absorption spectrum of this
solution by using UV–Vis spectrophotometer (Double Beam
Spectrophotometer 6800 JENWAY). An aliquot of the tested
solution was taken in a cuvette (quartz) and monitored for
wavelength scanning from 300 to 700 nm (Singh et al., 2014a).
Energy dispersive X-ray analysis (EDX)
Elemental analysis energy dispersive, X-ray analysis (EDX)
was done using X-ray microanalysis system coupled with
scanning electron microscope (SEM) (El-Agamy, 2014). It
was carried out at the Center of Biotechnology and Mycology,
El-Azhar University, Cairo, Egypt.
Fourier transform infrared spectroscopy (FT-IR)
For Fourier transform infra-red (FT-IR) spectroscopy mea-
surements, the bio-transformed products found in the extracel-
lular supernatant from S. rochei MHM13 were freeze dried
then diluted by potassium bromide (the ratio 1:100). The
FT-IR spectrum of the sample was monitored on FT-IR
instrument attached with diffuse reﬂectance mode (DRS-
800). All measurements were performed in the range from
400 to 4000 cm1 at a resolution of 4 cm1. To identify the
functional groups found in the tested sample, the spectral data
recorded were compared with the reference chart (Deepa et al.,
2013). It was carried out at the Center of Biotechnology and
Mycology, El-Azhar University; Cairo, Egypt.
Scanning electron microscopy (SEM)
SEM was carried out to observe the morphology, shape and
size of the produced nanoparticles. A specimen was performed
by casting a drop of the mixture on a carbon-coated copper
grid then, the excess solution was removed and allowed to
dry in the air. The study of scanning electron microscopy
was monitored on S-3400 2010 (Japan) at an accelerating volt-
age of 10,000 V (attached with a CCD camera) (Kumar et al.,
2015).
Application of Plackett–Burman design for optimization of the
culture conditions
The Plackett–Burman experimental design was applied to
evaluate the relative importance of various factors (Plackett
and Burman, 1946) involved in the production of silvernanoparticles by S. rochei MHM13 and its antibacterial activ-
ity against V. fluvialis. The seven independent variables tested
in this application and their settings are recorded in Table 1.
Each variable was examined in four trials at high level (+1)
and in four trials at low level (1). The eight different trials
and the basal control were performed in duplicate. The main
effect for each variable was measured with the following
equation:
Exi ¼
X
Miþ 
X
Mi
 
=N
where Exi is the main effect variable, Mi+ and Mi are the
radius (mm) of the inhibition zone around each well. Also,
the independent variable (xi) was present in low and high con-
centrations, respectively, while, N represented the number of
trials divided by 2. The statistical t-values for equal unpaired
samples were calculated using Microsoft Excel to measure
the variable signiﬁcance (Cochran and Snedecor, 1989). An
optimized medium was predicted from the main effect results.
Verification experiment
The predicted optimum levels for the independent variables
were carried out and compared with the basal conditions
and the averages of inhibition zones were calculated. This
experiment was performed in duplicates.
Silver nanoparticles and their antibiotic efficacy
The antimicrobial activity of the biosynthesized AgNPs was
examined against bacterial pathogens. The combined formula-
tion of silver nanoparticles with standard antibiotic discs
selected from different groups having a different mode of
action includes: Ciproﬂoxacin (CIP, 5 lg/disc; ﬂuoro-
quinolones group), Ampicillin (AM, 10 lg/disc; betalactam
antibiotics group), Streptomycin (S, 10 lg/disc), Gentamicin
(GN, 10 lg/disc; aminoglycoside), Tetracycline (TE, 10 lg/
disc; ulphoamides group), and Lincomycin (L, 2 lg/disc). They
were used to ﬁnd out the synergistic effect against the tested
bacterial pathogens. After incubation overnight at 37 C, the
inhibition zone (mm) was measured (Zarina and Nanda,
2014a). The increase in fold area was estimated by measuring
the mean surface area of the clear inhibition zone produced
by an antibiotic alone and in combination with silver nanopar-
ticles, (Fayaz et al., 2010; Zarina and Nanda, 2014a).
Table 2 Inhibition zone (mm) of the silver nanoparticles
(50 ll) synthesized by isolates 13 and 38 against some bacterial
pathogens.
Pathogenic bacteria Isolate 13 Isolate 38
AgNPs inhibition zone (mm)
Bacillus subtilis 18 16
Staphylococcus aureus 18 18
Pseudomonas aeruginosa 18 0
Bacillus cereus 16 14
Salmonella typhimurium 18 14
Escherichia coli 16 0
Vibrio fluvialis 19 15
Vibrio damsela 16 13
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Seawater (1 ml) was mixed with nutrient broth medium (20 ml)
(Oxoid Ltd, England) in conical ﬂask (50 ml) containing cover
glass and incubated overnight at 28 C. About 200 ll of silver
nanoparticles was added into the ﬂask (as an antifouling
agent). After dying with crystal violet solution (0.4%) for ten
minutes, the cover glass was washed by water, dried at room
temperature and observed under the microscope (Kumaran
et al., 2011). For comparison, a control ﬂask without silver
nanoparticles was used.
Anticancer activity
To evaluate the anticancer activity of AgNPs produced by S.
rochei HMM13, several steps were carried out: lyophilization,
cytotoxicity test (measured by MTT assay) and effect of the
median inhibitory dose (IC50) (Abd-Elnaby et al., 2016; El-
Sersy et al., 2012) on eight different tumour cell lines: Hepato-
cellular carcinoma cells (HepG-2), Breast carcinoma cells
(MCF-7), Colon carcinoma cells (HCT-116), Prostate carci-
noma cells (PC-3), Lung carcinoma cells (A-549), Intestinal
carcinoma cells (CACO), Larynx carcinoma cells (HEP-2)
and Cervical carcinoma cells (HELA).
Results and discussion
Screening for biosynthesis of silver nanoparticles
The current study was focused on the extracellular synthesis of
AgNPs by actinomycete supernatant. A total of forty one acti-
nomycetes were checked for their ability to produce silver
nanoparticles. The screening revealed that only two isolates;
13 and 38 showed the ability to synthesis AgNPs. The Erlen-
meyer ﬂasks with the actinomycetes supernatant was pale-
yellow in colour before the addition of silver ions and this col-
our changed to yellowish-brown at the end of the reaction with
silver ions (Fig. 1).
The yellowish-brown colour that appeared in the ﬂasks
mixed with silver nitrate was a clear indication of silver
nanoparticle formation (Sastry et al., 2003) due to the reduc-
tion of Ag+ ions and formation of surface plasmon resonance
in the reaction mixture, while no colour change appeared in
culture ﬁltrates without silver nitrate (Narasimha et al., 2013;Isolate 13                         
Figure 1 The supernatant of actinomycetes isolates (13 and 38) were
yellow colour) and after 72 h of incubation (a yellowish-brown colourZarina and Nanda, 2014a). The synthesis of nanoparticles by
actinomycetes has many advantages e.g. they are safe to han-
dle, easily available, and possess variable metabolites that may
help in reduction. Moreover, these particles have innumerable
applications (Deepa et al., 2013).
Antibacterial activity of silver nanoparticles
The microbiologically synthesized AgNPs exhibited an excel-
lent antibacterial activity against the bacterial pathogens both
gram negative and gram positive (Table 2). Silver nanoparti-
cles synthesized by actinomycete isolate 13 exhibited the max-
imum zones of inhibition (16–19 mm) against all tested
pathogenic bacteria, whereas, silver nanoparticles synthesized
by actinomycete isolate 38 exhibited moderate zones of inhibi-
tion (13–18 mm) against some tested pathogenic bacteria and
failed to inhibit two pathogens (Fig. 2). Generally, silver
nanoparticles produced by actinomycete isolate 13 showed
higher activity against the tested pathogens, and exhibited
the strong action against V. fluvialis, so it’s selected for further
studies.
The formation of inhibition zone around the well was an
indication of antibacterial activity of silver nanoparticles
(Narasimha et al., 2013). Silver nanoparticles exhibited a
broad bactericidal activity against gram positive and gram              Isolate 38
mixed with 1 mM AgNO3 at the beginning of incubation (a pale
).
(A)                                                  (B)                                                     (C)
Figure 2 Antagonistic effects of AgNPs synthesized by actinomycetes isolates 13 and 38 against (A): Vibrio fluvialis (B): Staphylococcus
aureus and (C): Bacillus subtilis.
Table 3 Phenotypic characteristics of Streptomyces rochei
MHM13.
Test Test
Diﬀusible pigments Beige Urea hydrolysis +
Aerial mycelium Grey Gelatin hydrolysis +
Substrate mycelium Yellow Protease
production
+
Growth on H2S production 
Starch nitrate agar + Methyl red +
Inorganic salts starch agar + Voges proskauer 
Krassilnikov agar + Indole 
Glycerol-nitrate agar + Nitrate reduction +
Glucose yeast-malt extract
agar
 Citrate +
Cazpex Dox agar + Catalase +
Oat meal agar + Starch +
Growth at (C) Aesculin +
25–30 + Arginine
dihydrolase
+
40–50 
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et al., 2007). Similarly, Jaidev and Narasimha (2010),
Narasimha et al. (2013) and Kamel et al. (2016) demonstrated
the reactive antimicrobial activity of silver nanoparticles. Also,
Saminathan (2015) showed that silver nanoparticles
synthesized by Streptomyces sp. have reactive antibacterial
activity against test pathogens including S. aureus, Proteus
vulgaris, E. coli, Shiegella dysentriae, Klebsiella pneumonia
and Salmonella typhi.
Identification of the most potent isolate
The most potent actinomycete (isolate 13) that produced silver
nanoparticles capable of inhibiting the growth of all tested
pathogenic bacteria was selected. This actinomycete was iden-
tiﬁed by phenotypic characterization and molecular phyloge-
netic analysis.
Genomic DNA of actinomycetes 13 was extracted, and the
16S rDNA gene was partially ampliﬁed. The produced ampli-
cons of the selected isolate was detected using agarose gel elec-
trophoresis. The sequence obtained from 16S rRNA gene
showed that the actinomycete isolate was similar to S. rochei
with an identity of 99%. The sequence of nucleotide was
deposited to the database of GenBank as S. rochei MHM13
with accession number KR108310. Fig. 3 represents the phylo-
genetic relationships between representative experimental
strains and the most closely related species. Some morphology,
cultural and biochemical characteristics of S. rochei MHM13
were studied and represented in Table 3. Also, Fig. 4 represents
the spore formation of S. rochei MHM13.Figure 3 Phylogenetic analysis of Streptomyces rochei MHM13
based on partial sequencing of 16S rDNA.
Figure 4 Scanning electron micrograph shows spore formation
of Streptomyces rochei MHM13 after 14 days of incubation on
starch-nitrate agar medium.Several studies reported the potential of Streptomyces sp. in
biosynthesized of silver nanoparticles (Samundeeswari et al.,
2012; Chauhan et al., 2013; Prakasham et al., 2014; Singh
306 H.M. Abd-Elnaby et al.et al., 2014a; Zarina and Nanda, 2014a,b; Saminathan, 2015).
Selvakumar et al., (2012) mentioned that AgNPs have been
successfully synthesized by marine S. rochei. Also, Reddy
et al. (2011) investigated the characterization of
S. rochei.
Characterization of silver nanoparticles synthesized by S. rochei
MHM13
UV–Visible spectroscopy
The absorption spectrum of the AgNPs synthesized by S.
rochei is illustrated in Fig. 5. The absorption obtained indi-Figure 5 UV–Vis absorption spectrum of AgNPs synthesized by
Streptomyces rochei MHM13 (treating by 1 mM AgNO3 solution
with actinobacteria supernatant).
Figure 6 X-ray microanalysis of AgNPs synthesized by Stcated a strong surface plasmon resonance band maximum at
410 nm, a characteristic peak for silver nanoparticles. The
absorbance peak reﬂects the size and shape of AgNO3 (Sosa
et al., 2003). The surface plasmon resonance peak shifts to
longer wavelengths with increase in particle size (Brause
et al., 2002). Samundeeswari et al. (2012) mentioned that the
extracellular synthesized silver nanoparticles by Streptomyces
albogriseolus were characterized by an ultraviolet visible spec-
trophotometer and the maximum absorption spectra was
observed at 409 nm. Similar results were showed by
Narasimha et al. (2013) and Zarina and Nanda (2014a).
Energy dispersive X-ray analysis (EDX)
The result of X-ray microanalysis of the silver peck in AgNPs
synthesized by S. rochei is represented in Fig. 6 which showed
the optical absorption peak at 3.5 keV, typical of absorption of
metallic silver nanoparticles. Silver nanoparticles have been
characterized using X-ray microanalysis (Shaligram et al.,
2009; Mohamedin et al., 2015).
Fourier transform infrared spectroscopy
The FT-IR gives insights about the presence of functional
groups in the synthesized silver nanoparticles in order to
understand how they transform from simple inorganic silver
nitrate to elemental silver due to the effect of different pho-
tochemicals that might act in a simultaneous way as reduc-
ing, stabilizing and capping agent. The spectrum of FTIR
evidently shows the bio fabrication of silver nanoparticles
mediated by S. rochei MHM13 at array of absorbance bands
from 400 to 4000 cm1. The FT-IR spectrum analysis for
AgNPs represented intense absorption bands at 3420.14,
2932.23, 2362.37, 1639.20, 1430.92, 1115.62 and
613.252 cm1, respectively. The intense medium absorbance
peak at 3420.14 cm1 (N–H stretch) was characteristic of
the amine group (Fig. 7, Table 4). Similar results were
reported by Zarina and Nanda (2014a,b), Singh et al.
(2014a), Prakasham et al. (2014) and Lakhsmi et al. (2015).
The studies of FT-IR conﬁrmed the fact that amide groups
of proteins have a stronger ability to bind metal which indi-
cates that the proteins act as capping agent for stabilizing the
nanoparticles (Zayed et al., 2012).reptomyces rochei MHM13 with silver peak at 3.5 keV.
Figure 7 FT-IR analysis of AgNPs synthesized by Streptomyces rochei MHM13.
Table 4 FT-IR analysis of AgNPs synthesized by Strepto-
myces rochei MHM13.
Peak
No.
Group frequency
(cm1)
Functional group assignment
1 3420.14 NAH (stretch primary amine)
2 2932.23 CAH (stretch alkane)
3 2362.37 O‚C‚O (stretch carbon dioxide)
4 1639.20 C‚C (stretch alkene)
5 1430.92 CAH (bend alkane)
6 1115.62 CAO (stretch aliphatic ether)
7 613.252 CACl or CABr (stretch halo
compounds)
Figure 8 SEM analysis of AgNPs synthesized by Streptomyces
rochei MHM13.
Table 5 The experimental results of Plackett–Burman design
for seven variables affecting antibacterial activity of AgNPs
against Vibrio fluvialis.
Trials Starch KN K2 Mg Fe Temp pH Inhibition
zone (mm)
1  + + +    18
2 + +     + 26
3 +  +   +  16
4    +  + + 22
5 +   + +   18
6   +  +  + 25
7  +   + +  22
8 + + + + + + + 0
9 0 0 0 0 0 0 0 20
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The scanning electron microscope analysis was carried out to
depict the shape and size of the silver nanoparticles synthesized
by S. rochei MHM13. The SEM shows that the bacterium has
tremendous capability to synthesize silver nanoparticles which
were well deﬁned separated as much as possible, spherical in
shape. The obtained nanoparticles were in the size ranging
from 22 to 85 nm (Fig. 8). Deepa et al. (2013) reported that sil-
ver nanoparticles synthesized from marine Actinomycetes
shows size of nanoparticles ranging from 20 to 30 nm.
Saminathan (2015) showed that the average size of biosynthe-
sized silver nanoparticles were greater than 50 nm and spheri-
cal in shape. While Bhosale et al. (2015) found that the
biosynthesized silver nanoparticles were irregular in shape.
Also, Devika et al. (2012) mentioned that the spherical
nanoparticles have diameter that ranged from 40 to 50 nm.
Faghri and Salouti (2011) found that the extracellular biosyn-
thesized silver nanoparticles were spherical and the size ranged
from 10 to100 nm.
Optimization of the culture conditions by application of
Plackett–Burman design
This design has been applied to evaluate the signiﬁcant effect
of starch nitrate medium components for production of
AgNPs by S. rochei MHM13 and its antibacterial activity
against V. fluvialis. The starch nitrate medium components
and other cultural factors such as pH and temperature were
tested according to a design matrix (Table 5) with respect tothe AgNPs production and its effect against the ﬁsh pathogen
V. fluvialis.
The main effects of each variable on the diameters of inhi-
bition zones were calculated and the t-values were estimated
for each variable to identify the statistical signiﬁcance of the
measured response and determine the main effects for S. rochei
MHM13 (Table 6). Based on the present results, the low level
Table 6 Statistical analyses of the Plackett–Burman experi-
mental results.
Variable Main eﬀect t-value*
Starch 0.25 2.353
KNO3 6.75 2.131
K2HPO4 4.25 2.131
MgSO47H2O 7.75 2.131
FeSO4 7.75 2.131
Temperature 6.75 2.353
pH 3.75 2.131
t-value, signiﬁcant at 5% level = 2.446.
t-value, signiﬁcant at 10% level = 1.94.
t-value, signiﬁcant at 20% level = 1.372.
Standard t-values are obtained from Statistical Methods by
Cochran and Snedecor (1989).
* t-value, signiﬁcant at 1% level = 3.70.
Figure 10 Activity of AgNPs synthesized by Streptomyces rochei
MHM13 against Vibrio fluvialis grown on optimized medium.
Figure 11 SEM analysis of AgNPs synthesized by Streptomyces
rochei MHM13 after growth on optimized medium.
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sion of bacterial pathogen (V. fluvialis) with respect to produc-
tion of the of silver nanoparticles by S. rochei MHM13
(Fig. 9).
Verification experiment
This experiment was carried out to verify the optimization
conditions to validate the obtained optimized medium. S.
rochei was grown on the optimized medium of the following
components (g l1): 10 starch, 0.5 KNO3, 0.25 K2HPO4, 0.25
MgSO47H2O, 0.005 FeSO4, at pH 6.5 and 33 C, recorded
the larger inhibition zone (24 mm) than that in the basal con-
ditions by 1.26 fold increase. The present result conﬁrmed the
validity of the optimized conditions (Fig. 10). The size of
AgNPs synthesized by S. rocheiMHM13 after growth on opti-
mized conditions decreased to the range from 18 to 27 nm
(Fig. 11). The smaller silver nanoparticles showed stronger
antibacterial activity (Abdeen et al., 2014).
Mohamedin et al. (2015) found that among the fourteen
variables tested, peptone concentration medium volume and
inoculum age were the most signiﬁcant factors for silver
nanoparticles production from Streptomyces viridodiastaticus.
Singh et al. (2014b) reported that, the maximum AgNPs pro-Figure 9 Main effect of the different factors inﬂuencing thduction was achieved at 25 C while at high temperature
(40 C) the enzyme activity decreased so the synthesis of
AgNPs slows down in the reaction. On the other hand, the
internal environment of living cells is believed to be nearly neu-
tral, so the activity of bacteria decreased as the pH deviatese AgNPs synthesized by Streptomyces rochei MHM13.
Table 7 Synergistic effect of antibiotics with and without silver nanoparticles against different pathogenic bacteria.
Pathogenic bacteria Antibiotic Inhibition zone (mm)
Ab* Ab + AgNPs**
Vibrio fluvialis Ciproﬂoxacin 20 22
Ampicillin – 15
Streptomycin – 22
Gentamicin 8 20
Tetracycline – 10
Lincomycin – 18
Vibrio damsela Ciproﬂoxacin 20 30
Ampicillin 20 25
Streptomycin 10 25
Gentamicin 20 25
Tetracycline – 25
Lincomycin – 20
Salmonella typhimurium Ciproﬂoxacin 12 25
Ampicillin – 15
Streptomycin – 18
Gentamicin 4 25
Tetracycline – 8
Lincomycin – 20
Escherichia coli Ciproﬂoxacin 18 20
Ampicillin – 15
Streptomycin – 18
Gentamicin 12 20
Tetracycline – 12
Lincomycin – 22
* Ab = antibiotic alone.
** Ab + AgNPs = antibiotic with silver nanoparticles.
Figure 12 Synergistic effect of various antibiotics with and
without AgNPs against Vibrio fluvialis.
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and Abdelwahed, 2014; Mohamedin et al., 2015).
Synergetic effect of silver nanoparticles with antibiotics
The various bacterial pathogens exhibited different susceptibil-
ities to AgNPs. The combined effect of AgNPs with six stan-
dard antibiotic discs (Ciproﬂoxacin, Ampicillin,
Streptomycin, Gentamicin, Tetracycline and Lincomycin)
was observed against some multi drug resistant pathogenic
bacteria. The inhibition zones diameters for antibiotics alone
and in combination with AgNPs developed signiﬁcant increase
in the fold area for all tested cases (Table 7). The antibacterial
activity of the tested antibiotics increased in the presence of
AgNPs against test bacterial pathogens (Fig. 12). Similar
results were observed by previous studies (Fayaz et al., 2010;
Zarina and Nanda, 2014a,b). The combination of AgNPs with
antibiotics has better antimicrobial effects. This combination
would prevent a development of resistance by pathogenic
microbes and also enhance the antimicrobial properties of
the antibiotics, moreover, would also decrease the dosage of
antibiotic against multi-drugs resistance pathogenic microbes.
Anti-fouling activity of silver nanoparticles
The inhibitory activity of S. rochei HMM13 silver nanoparti-
cles on bacterial bioﬁlm formation is illustrated in Fig. 13.
The AgNPs reduced the density of bacterial cells and acted
as an anti-biofouling agent. The present result agreed with
Figure 13 Photographs illustrating the antifouling effect of the AgNPs from S. rochei HMM13 on the bioﬁlm formation (A) and the
effect without the silver nanoparticles (B).
Table 8 IC50 determination cell viability was measured by
MTT assays on different cancer cell lines after 24 h exposure to
doses of AgNPs produced by S. rochei HMM13.
Cell line IC50 (lg/Well)
HepG2 32.90
HCT-116 9.05
MCF-7 40.00
PC-3 48.50
A-549 42.10
CACO >50
HEP-2 >50
HELA >50
310 H.M. Abd-Elnaby et al.the study of Sawada et al. (2012) on membrane containing
AgNPs with both antibacterial properties and organic
antifouling. The study explained that, more than 99.9% of
E. coli cells were inhibited, suggesting that, the AgNPs were
useful for inhibiting bacterial growth.
Anticancer activity of silver nanoparticles
As clearly shown in Tables 8 and 9, the effect of silver
nanoparticles on a tumour cell line showed a dose-dependentTable 9 Anticancer activity for different concentrations of AgNPs w
lines (measured by MTT assays after 24 h exposure).
AgNPs conc. (lg/Well) HepG-2 MCF-7 HCT-116
Viability%
50.00 21.63 36.42 17.97
25.00 63.14 70.31 24.85
12.50 78.92 84.19 37.28
6.25 89.56 89.27 60.35
3.13 94.32 94.53 83.51
1.56 98.75 97.46 91.84
0.00 100.00 100.00 100.00
Hepatocellular carcinoma cells (HepG-2), breast carcinoma cells (MCF-7
lung carcinoma cells (A-549), intestinal carcinoma cells (CACO), larynxdecrease in viability percentage of cell lines. Silver nanoparti-
cles from S. rochei HMM13 exhibited a reasonable degree of
anticancer activity after a 24 h exposure to different concentra-
tions of AgNPs, where Hep-G2, HCT-116, A-549 and MCF-7,
PC-3 cell lines were the most sensitive cell lines towards the
cytotoxic activity of the tested AgNPs, while the CACO,
HEP-2, HELA cell lines were the most resistant cell lines
towards the cytotoxic activity. In similar results, Kaler et al.
(2013) reported that silver nanoparticles at very low concentra-
tion showed very high activity on MCF-7 cells, showing almost
80% inhibition. At higher concentration (10–100 lg/mL) no
signiﬁcant difference in inhibition of cancer cells was observed
with silver nanoparticles and the IC50 value for the silver
nanoparticles was less than 10 lg/ml. Also, Shawkey et al.
(2013) found that the HCT-116 and Hep-G2 cell lines were
the most sensitive cell lines towards the cytotoxic activity of
AgNPs, while the Caco-2 cell line was the most resistant cell
line towards cytotoxic activity.
Conclusion
A crucial need in the ﬁeld of nanotechnology is the develop-
ment of eco-friendly and reliable process for nanoparticles
synthesis. It is thus concluded from this study that the marinehich produced by S. rochei HMM13 against different cancer cell
PC-3 A-549 CACO HEP-2 HELA
48.13 38.59 54.31 63.82 56.79
79.24 74.62 78.29 85.17 74.13
91.36 87.31 91.45 94.26 85.82
98.63 94.05 98.73 99.02 92.45
100.00 98.79 100.00 100.00 98.37
100.00 100.00 100.00 100.00 100.00
100.00 100.00 100.00 100.00 100.00
), colon carcinoma cells (HCT-116), prostate carcinoma cells (PC-3),
carcinoma cells (HEP-2) and cervical carcinoma cells (HELA).
Antibacterial and anticancer activity of extracellular synthesized 311S. rochei HMM13 has been used efﬁciently for AgNPs’ synthe-
sis. We have described the use of low cost, natural and renew-
able bio-reducing agent. It was conﬁrmed that AgNPs can be
bio-synthesized by UV–Visible spectroscopy, EDX, FT-IR
and SEM. Optimization of the culture conditions for S. rochei
HMM13 decreased the size of synthesized AgNPs to the range
from 18 to 27 nm. The biosynthesized AgNPs using S. rochei
HMM13 showed good antibacterial, antifouling and anti-
cancer activity.
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